Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

3,011

Participants

Timeline

Start Date

June 12, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Epidemic Meningitis

Interventions

BIOLOGICAL

MCV4

4 doses of vaccine on Day 0, Day30, Day 60 and Month 12

Trial Locations (1)

Nanjing Luhe District Center for Disease Control and Prevention Center for Disease Control and Prevention, Nanjing